Trieu Vuong - Aug 25, 2022 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Stock symbol
OTLC
Transactions as of
Aug 25, 2022
Transactions value $
$6,560
Form type
4
Date filed
8/29/2022, 09:15 AM
Previous filing
Sep 8, 2021
Next filing
Sep 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $6.56K +80K +0.09% $0.08 90.3M Aug 25, 2022 Direct
holding OTLC Common Stock 16.8M Aug 25, 2022 By Autotelic, Inc.
holding OTLC Common Stock 6.87M Aug 25, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 80,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on August 25, 2022 from the open market at a price of $0.082.